Related Experiment Video
Updated: May 27, 2026
06:09
Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
Published on: May 30, 2025
Clearing the smoke around medical marijuana
1Department of Family Medicine and Department of Anesthesia, McGill University, Montreal, Quebec, Canada. mark.ware@muhc.mcgill.ca
Clinical Pharmacology and Therapeutics
|November 18, 2011
Summary
Vaporized cannabis (medical marijuana) did not significantly alter opioid levels in patients with chronic pain. This study suggests cannabis may enhance the pain-relieving effects of opioids like oxycodone and morphine.
Area of Science:
- Pharmacology
- Pain Management
- Cannabis Research
Background:
- The use of medical marijuana for chronic pain lacks robust clinical data.
- Understanding drug interactions between cannabis and opioids is crucial for patient safety and effective pain management.
Purpose of the Study:
- To investigate the pharmacokinetic interaction between vaporized cannabis and opioid analgesics.
- To assess the impact of cannabis on the efficacy of oxycodone and morphine in chronic non-cancer pain.
Main Methods:
- Observational study analyzing opioid plasma levels in patients using vaporized cannabis.
- Clinical assessment of pain scores and analgesic efficacy in patients with chronic non-cancer pain.
Main Results:
- Vaporized cannabis did not produce clinically significant changes in plasma concentrations of oxycodone or morphine.
- Evidence suggests a potential synergistic effect, where cannabis may augment opioid efficacy.
Conclusions:
- Vaporized cannabis appears to be safe from a pharmacokinetic interaction perspective with common opioids.
- Further research is warranted to explore the potential analgesic synergy between cannabis and opioids for chronic pain management.
Related Concept Videos
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
01:25Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
01:06Drug Elimination: The Concept of Clearance
Drug elimination refers to removing drugs from the body, either through urine by the kidneys or through bile by the liver. Drug clearance is a pharmacokinetic parameter that measures the efficiency of drug removal from the bloodstream within a specific time frame. It is calculated as the rate at which a drug is eliminated from plasma divided by the plasma concentration of the drug.
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination,...
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination,...
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...